Blueberries Medical (BBRRF) Ratios
Blueberries Medical Ratios
BBRRF's free cash flow for Q2 2026 was $-298.23K. For the 2026 fiscal year, BBRRF's free cash flow was increased by $0.00 and operating cash flow was $-298.23K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.95 | 1.84 | 4.15 | 1.25 | 0.81 |
| Quick Ratio | 0.88 | 1.39 | 3.59 | 1.24 | 0.81 |
| Cash Ratio | 0.07 | 0.12 | 1.78 | 0.81 | 0.69 |
| Solvency Ratio | -4.37 | -1.91 | -3.16 | -0.62 | -2.00 |
| Operating Cash Flow Ratio | -3.47 | -1.46 | -2.90 | -0.84 | -0.87 |
| Short-Term Operating Cash Flow Coverage | -9.51 | -69.64 | 0.00 | -1.28 | -1.52 |
| Net Current Asset Value | $ -16.82K | $ 457.39K | $ 1.44M | $ 299.25K | $ -595.52K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.01 | 0.01 | 0.40 | 0.40 |
| Debt-to-Equity Ratio | 0.43 | 0.01 | 0.01 | 0.91 | 1.00 |
| Debt-to-Capital Ratio | 0.30 | 0.01 | 0.01 | 0.48 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.12 | 1.65 | 1.24 | 2.29 | 2.50 |
| Debt Service Coverage Ratio | -9.80 | -91.18 | -4.63 | -0.17 | -3.07 |
| Interest Coverage Ratio | 0.00 | 0.00 | -5.22 | -4.56 | -6.64 |
| Debt to Market Cap | 0.03 | 0.00 | 0.00 | 0.45 | 0.11 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net Debt to EBITDA | -0.09 | 0.05 | 0.66 | 0.09 | -0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.85% | 34.90% | 29.22% | -7.53% | -176.91% |
| EBIT Margin | -441.57% | -243.64% | -475.78% | -470.50% | -3515.46% |
| EBITDA Margin | -410.08% | -221.32% | -423.83% | -344.65% | -2918.42% |
| Operating Profit Margin | -441.57% | -193.70% | -477.44% | -696.79% | -1289.55% |
| Pretax Profit Margin | -533.44% | -243.64% | -567.30% | -623.44% | -3709.64% |
| Net Profit Margin | -533.44% | -243.64% | -567.30% | -623.44% | -3709.64% |
| Continuous Operations Profit Margin | -533.44% | -243.64% | -567.30% | -623.44% | -3709.64% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 120.81% | 125.78% | 118.82% | 89.47% | 287.67% |
| Return on Assets (ROA) | -245.12% | -83.20% | -67.67% | -43.76% | -143.22% |
| Return on Equity (ROE) | -518.68% | -137.58% | -84.04% | -100.01% | -358.74% |
| Return on Capital Employed (ROCE) | -429.35% | -109.38% | -70.33% | -102.11% | -107.91% |
| Return on Invested Capital (ROIC) | -300.40% | -106.46% | -70.27% | -36.57% | -62.26% |
| Return on Tangible Assets | -245.12% | -83.20% | -67.67% | -43.76% | -143.22% |
| Earnings Yield | -35.22% | -28.78% | -37.29% | -57.94% | -49.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.11 | 1.20 | 0.93 | 0.92 | 0.69 |
| Payables Turnover | 1.34 | 0.59 | 0.47 | 0.56 | 1.27 |
| Inventory Turnover | 10.09 | 1.25 | 0.78 | 20.56 | 0.00 |
| Fixed Asset Turnover | 23.89 | 1.25 | 0.57 | 0.20 | 0.07 |
| Asset Turnover | 0.46 | 0.34 | 0.12 | 0.07 | 0.04 |
| Working Capital Turnover Ratio | 1.42 | 0.49 | 0.31 | 7.13 | -0.14 |
| Cash Conversion Cycle | 91.29 | -20.04 | 77.76 | -233.44 | 242.70 |
| Days of Sales Outstanding | 327.37 | 303.08 | 392.97 | 396.74 | 531.09 |
| Days of Inventory Outstanding | 36.17 | 291.40 | 466.36 | 17.75 | 0.00 |
| Days of Payables Outstanding | 272.26 | 614.52 | 781.57 | 647.93 | 288.39 |
| Operating Cycle | 363.54 | 594.47 | 859.33 | 414.49 | 531.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -59.61 | -489515.67 | -34.45 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -59.61 | -489515.67 | -34.45 |
| Operating Cash Flow Coverage Ratio | -9.02 | -69.64 | -104.07 | -1.10 | -1.17 |
| Operating Cash Flow to Sales Ratio | -3.98 | -1.69 | -4.62 | -6.24 | -12.11 |
| Free Cash Flow Yield | -26.28% | -19.97% | -30.89% | -57.97% | -16.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.86 | -3.47 | -2.68 | -1.73 | -2.02 |
| Price-to-Sales (P/S) Ratio | 15.15 | 8.46 | 15.21 | 10.76 | 74.92 |
| Price-to-Book (P/B) Ratio | 14.73 | 4.78 | 2.25 | 1.73 | 7.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.80 | -5.01 | -3.24 | -1.73 | -6.01 |
| Price-to-Operating Cash Flow Ratio | -3.80 | -5.01 | -3.29 | -1.73 | -6.19 |
| Price-to-Earnings Growth (PEG) Ratio | -0.14 | 0.06 | 0.19 | 0.02 | 0.15 |
| Enterprise Value Multiple | -3.78 | -3.77 | -2.93 | -3.03 | -2.59 |
| Enterprise Value | 4.84M | 3.94M | 3.58M | 2.46M | 10.49M |
| EV to EBITDA | -3.78 | -3.77 | -2.93 | -3.03 | -2.59 |
| EV to Sales | 15.50 | 8.35 | 12.42 | 10.44 | 75.61 |
| EV to Free Cash Flow | -3.89 | -4.94 | -2.64 | -1.67 | -6.07 |
| EV to Operating Cash Flow | -3.89 | -4.94 | -2.69 | -1.67 | -6.24 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.37 | -0.03 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.21 | 1.00 | 1.19 | 1.33 | 1.06 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 4.18 | 2.06 | 4.29 | 5.21 | 3.84 |
| Stock-Based Compensation to Revenue | 0.06 | 0.10 | 0.39 | 0.57 | -2.45 |
| Income Quality | 0.75 | 0.69 | 0.81 | 1.00 | 0.33 |
Currency in CAD